Search clinical trials for: Vinorebine, Everolimus
Total 1371 results
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Seung-Jung ParkAbbott Medical Devices; CardioVascular Research Foundation, KoreaTerminatedCoronary Artery DiseaseThailand, Korea, Republic of, China, Malaysia
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Novartis PharmaceuticalsCompleted
-
Henan Cancer HospitalRecruiting
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
The Netherlands Cancer InstituteActive, not recruitingNeuroendocrine CarcinomasNetherlands
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
-
University of LuebeckTerminatedCoronary Artery DiseaseGermany
-
QLT Inc.TerminatedStage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
-
Guangdong Provincial People's HospitalNovartisUnknownNeuroendocrine Tumors | Carcinoid TumorChina
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
Novartis PharmaceuticalsTerminatedCarcinoma, Renal CellAustralia, Korea, Republic of
-
Centre Leon BerardSuspended
-
Leiden University Medical CenterUnknownHead and Neck CancerNetherlands
-
ARCAGY/ GINECO GROUPCompletedEndometrial CancerFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Dana-Farber Cancer Institute; Novartis PharmaceuticalsCompletedMalignant Pleural MesotheliomaUnited States
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Yonsei UniversityUnknown
-
Abbott Medical DevicesCompletedAtherosclerosis | Peripheral Vascular DiseaseGermany, Austria, Belgium, Italy
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedHER-2 Positive Breast CancerUnited States
-
Asan Medical CenterCompletedStomach NeoplasmKorea, Republic of
-
Samsung Medical CenterCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminated
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina
-
Asan Medical CenterCompletedStomach NeoplasmKorea, Republic of
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
Bayside HealthUnknownAcute Myeloid LeukemiaAustralia
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Dana-Farber Cancer InstituteNovartis; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedGlioma | Astrocytoma | Low-grade GliomaUnited States
-
Umberto I Hospital, Frosinone ItalyUnknownAcute Myocardial Infarction | Artery; Deformity, Coronary (Acquired)Italy
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisIndia
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisIreland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
Julie E. Bauman, MD, MPHNovartisTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Germany
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Radboud University Medical CenterNovartisCompletedBreast NeoplasmsNetherlands
-
Novartis PharmaceuticalsCompleted
-
Hopital FochCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Dana-Farber Cancer InstituteM.D. Anderson Cancer Center; Massachusetts General Hospital; Novartis; MOUNT SINAI...Completed
-
Novartis PharmaceuticalsCompletedBreast Neoplasms | Neoplasm MetastasisBelgium, Italy, Poland, Sweden, France
-
Abbott Medical DevicesTerminatedAtherosclerosis | Peripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Claudication | Critical Limb Ischemia | PAD | PVD | Lower Limb Disease | PAODBelgium
-
Linda C. HigginsUniversity of Texas Southwestern Medical CenterTerminatedKidney CancerUnited States